Published in Innate Immun on April 01, 2009
Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38. EMBO J (2014) 0.94
A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis. PLoS One (2012) 0.92
Calcineurin/NFAT signalling inhibits myeloid haematopoiesis. EMBO Mol Med (2012) 0.91
Nuclear presence of nuclear factor of activated T cells (NFAT) c3 and c4 is required for Toll-like receptor-activated innate inflammatory response of monocytes/macrophages. Cell Signal (2011) 0.88
Calcineurin/NFAT signaling and innate host defence: a role for NOD1-mediated phagocytic functions. Cell Commun Signal (2014) 0.87
Understanding the role of host hemocytes in a squid/vibrio symbiosis using transcriptomics and proteomics. Front Immunol (2012) 0.85
Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients. PLoS Pathog (2013) 0.83
Regulatory myeloid cells in transplantation. Transplantation (2014) 0.83
Nuclear factor of activated T cells regulates neutrophil recruitment, systemic inflammation, and T-cell dysfunction in abdominal sepsis. Infect Immun (2014) 0.79
The calcineurin inhibitor cyclosporine A improves lipopolysaccharide-induced vascular dysfunction but does not rescue from cardiovascular collapse in endotoxemic mice. Pflugers Arch (2013) 0.77
Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine Kinase. J Immunol (2017) 0.75
Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy. EMBO Mol Med (2017) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
Toll-like receptors and innate immunity. Nat Rev Immunol (2001) 16.50
NF-kappaB regulation in the immune system. Nat Rev Immunol (2002) 15.80
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A (2000) 9.67
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature (1992) 8.15
Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature (2007) 7.34
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) (1987) 7.07
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature (1992) 5.75
Calcineurin: form and function. Physiol Rev (2000) 5.26
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) (1987) 4.54
Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell (1999) 4.19
Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem (1998) 4.02
Cecal ligation and puncture. Shock (2005) 3.93
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A (1979) 3.33
Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care (2006) 3.19
The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol (2006) 3.11
Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol (2000) 3.07
Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry (1992) 3.05
Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology (1976) 2.76
Toll-like receptors and innate immunity. J Mol Med (Berl) (2006) 2.65
Molecular mechanisms of endotoxin tolerance. J Endotoxin Res (2004) 2.60
Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell (1991) 2.58
Endotoxin tolerance: A review. Crit Care Med (2002) 2.33
Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc (1987) 2.30
Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med (2005) 2.26
Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun (1988) 2.23
Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity (2004) 2.20
Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest (1990) 2.12
Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res (2003) 1.87
Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res (2006) 1.86
The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity (2006) 1.83
Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol (2000) 1.73
Transcription factor expression in lipopolysaccharide-activated peripheral-blood-derived mononuclear cells. Proc Natl Acad Sci U S A (2007) 1.63
Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock (2008) 1.48
Evaluation of endotoxin models for the study of sepsis. Shock (2005) 1.47
Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol (1993) 1.45
Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun (1986) 1.42
Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun (2001) 1.40
Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice. Genesis (2005) 1.37
Calcineurin negatively regulates TLR-mediated activation pathways. J Immunol (2007) 1.33
Calcineurin as a multifunctional regulator. J Biochem (2002) 1.29
Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg (1989) 1.26
Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol (1998) 1.22
Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol (2007) 1.19
Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun (2000) 1.10
Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation (1999) 1.05
Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity. Eur J Immunol (1993) 1.03
Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms. J Infect Dis (1997) 1.02
Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc (1987) 0.96
Tolerance to endotoxin in vitro: independent regulation of interleukin-1, tumor necrosis factor and interferon alpha production during in vitro differentiation of human monocytes. Lymphokine Res (1990) 0.94
A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Lupus (2007) 0.92
Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions. Proc Natl Acad Sci U S A (1999) 0.92
Cyclosporine preconditions dendritic cells during differentiation and reduces IL-2 and IL-12 production following activation: a potential tolerogenic effect. Transplant Proc (2003) 0.83
Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med (2000) 0.81
Topical tacrolimus: a review of its uses in dermatology. Dermatitis (2005) 0.80
Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens. Curr Opin Infect Dis (2005) 0.79
Calcineurin negatively regulates TLR-mediated activation pathways. J Immunol (2007) 1.33
Microfluidic sonicator for real-time disruption of eukaryotic cells and bacterial spores for DNA analysis. Ultrasound Med Biol (2005) 0.93
Synthesis of 2'-deoxy-2'-[18F]fluoro-9-β-D-arabinofuranosylguanine: a novel agent for imaging T-cell activation with PET. Mol Imaging Biol (2011) 0.92
Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors. Hematol Oncol (2010) 0.91
Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia. J Infect Dis (2006) 0.90
Reactive oxygen species regulate nucleostemin oligomerization and protein degradation. J Biol Chem (2011) 0.77
Gender differences and performance in science. Science (2005) 0.77